Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- English Abstract1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Arch Geschwulstforsch1
Search Results
Sort by
- BookDehner, Louis P.; Husain, Aliya N.Summary: "Virtually all aspects of the pathology in children are unique in pathogenesis and histogenesis from the moment of conception to adolescence whose range includes developmental anomalies to dysembryonic neoplasms. Stocker and Dehner’s Pediatric Pathology provides encyclopedic but very usable coverage of this complex subspecialty, detailing all major aspects of the pathologic anatomy of childhood disorders ranging from chromosomal syndromes and infections to forensic pathology. Upholding the standard of excellence established in previous editions, this thoroughly updated Fifth Edition offers the in-depth, richly illustrated guidance you need to confidently evaluate and dependably report your findings"-- Provided by publisherDigital Access Ovid 2021
- ArticleTeichmann B, Hauschild F.Arch Geschwulstforsch. 1978;48(4):301-7.0,0-Dimethyl(1-hydroxy-2,2,2-trichloroethyl)-phosphonate (Trichlorfon; TCP) was tested for carcinogenic activity in male and female mice derived from strain AB/Jena by oral (oesophageal-gastric intubation), intraperitoneal and dermal administration. The maximum period of treatment was 73 (oral), 73 (intraperitoneal) or 75 (dermal) weeks. During this period the following maximum mean total doses of TCP per animal had been administered: 157.5 mg(male, oral), 154 mg (female, oral), 160.8 mg (male, intraperitoneal), 149.7 mg (female, intraperitoneal). The dermally treated male and female mice had received a maximum total dose of 375 mg per animal. The study was terminated at 80 weeks. There is no statistic significant difference when compared the total tumour incidence of TCP-treated animals and control mice or the incidence of the different corresponding groups of mice separated by the route of administration or the incidence of malignant and benign tumours separated for the different groups. These findings were independent from whether the groups of TCP-treated animals and solvent control animals were combined or divided by sex for comparison.